Table 3 Antimicrobial resistance among the most relevant aetiologies of community-onset bloodstream infections in community-acquired and healthcare-related episodes
CA episodes | HCA episodes | P value | |
|---|---|---|---|
Escherichia coli | N = 57 | N = 71 | |
Amoxicillin-clavulanic acid-resistant | 9 (15.7) | 9 (12.6) | 0.61 |
Cefotaxime-resistant1 | 5 (8.7) | 6 (8.4) | 0.94 |
Ciprofloxacin-resistant | 14 (24.5) | 26 (36.6) | 0.14 |
Gentamycin-resistant | 2 (3.5) | 5 (7.0) | 0.46 |
Any resistance | 15 (26.3) | 25 (35.2) | 0.33 |
Klebsiella spp. | N = 12 | N = 13 | |
Amoxicillin-clavulanic acid-resistant | 2 (16.6) | 4 (30.7) | 0.64 |
Cefotaxime-resistant1 | 1 (8.3) | 1 (7.6) | 1.0 |
Ciprofloxacin-resistant | 0 | 1 (7.6) | 1.0 |
Gentamycin-resistant | 0 | 2 (15.3) | 0.48 |
Any resistance | 2 (16.6) | 3 (23.0) | 1.0 |
Pseudomonas aeruginosa | N = 1 | N = 13 | |
Ceftazidime-resistant | 0 | 1 (7.6) | - |
Imipenem-resistant | 0 | 2 (15.3) | - |
Ciprofloxacin-resistant | 0 | 2 (15.3) | - |
Amikacin-resistant | 0 | 0 | - |
Streptococcus pneumoniae | N = 27 | N = 11 | |
Penicillin-resistant | 2 (7.4) | 5 (45.4) | 0.01 |
Erithromycin-resistant | 2 (7.4) | 1 (9.0) | 0.56 |
Levofloxacin-resistant | 0 | 1 (9.0) | 0.28 |
Any resistance | 2 (7.4) | 5 (45.4) | 0.01 |
Staphylococcus aureus | N = 10 | N = 22 | |
Methicillin-resistant | 0 | 6 (27.2) | 0.14 |
All isolates | N = 1592 | N = 2032 | |
Any resistance | 32 (20.1) | 71 (34.9) | 0.001 |
Multi-drug resistance | 10 (6.2) | 22 (10.8) | 0.18 |